tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BRRGF Stock Latest News

Oncoinvent Registers Share Capital Increase Ahead of Reverse Share Split
Company AnnouncementsOncoinvent Registers Share Capital Increase Ahead of Reverse Share Split
1M ago
Oncoinvent Launches 100-for-1 Reverse Share Split and New ISIN on Oslo Bourse
PremiumCompany Announcements
Oncoinvent Launches 100-for-1 Reverse Share Split and New ISIN on Oslo Bourse
1M ago
Oncoinvent Grants New CEO Multiyear Share Option Package Tied to Long-Term Growth
PremiumCompany Announcements
Oncoinvent Grants New CEO Multiyear Share Option Package Tied to Long-Term Growth
1M ago
Oncoinvent Reshapes Capital Structure After Extraordinary General Meeting
PremiumCompany Announcements
Oncoinvent Reshapes Capital Structure After Extraordinary General Meeting
1M ago
Oncoinvent Revamps Option Scheme and Issues New Grants After BerGenBio Merger
PremiumCompany Announcements
Oncoinvent Revamps Option Scheme and Issues New Grants After BerGenBio Merger
2M ago
Oncoinvent Calls Extraordinary General Meeting to Reshape Capital Structure
PremiumCompany AnnouncementsOncoinvent Calls Extraordinary General Meeting to Reshape Capital Structure
2M ago
Oncoinvent ASA Completes Rights Issue and Share Capital Adjustment
Premium
Company Announcements
Oncoinvent ASA Completes Rights Issue and Share Capital Adjustment
2M ago
Oncoinvent’s Radspherin® Shows Promise in Ovarian Cancer Treatment
Premium
Company Announcements
Oncoinvent’s Radspherin® Shows Promise in Ovarian Cancer Treatment
2M ago
Oncoinvent ASA Announces Rights Issue and Underwriting Commission
PremiumCompany Announcements
Oncoinvent ASA Announces Rights Issue and Underwriting Commission
2M ago
Oncoinvent ASA Completes Major Rights Issue
PremiumCompany Announcements
Oncoinvent ASA Completes Major Rights Issue
3M ago
Oncoinvent ASA Completes NOK 130 Million Rights Issue to Bolster Cancer Therapy Development
PremiumCompany Announcements
Oncoinvent ASA Completes NOK 130 Million Rights Issue to Bolster Cancer Therapy Development
3M ago
Oncoinvent ASA Completes Subscription Period for Rights Issue
PremiumCompany Announcements
Oncoinvent ASA Completes Subscription Period for Rights Issue
3M ago
Oncoinvent ASA Rights Issue Subscription Period Closes
PremiumCompany AnnouncementsOncoinvent ASA Rights Issue Subscription Period Closes
3M ago
Oncoinvent ASA Completes Major Rights Issue with Insider Participation
Premium
Company Announcements
Oncoinvent ASA Completes Major Rights Issue with Insider Participation
3M ago
Oncoinvent ASA Rights Issue Nears Completion
Premium
Company Announcements
Oncoinvent ASA Rights Issue Nears Completion
3M ago
Oncoinvent ASA Launches NOK 130 Million Rights Issue
PremiumCompany Announcements
Oncoinvent ASA Launches NOK 130 Million Rights Issue
3M ago
Oncoinvent ASA Announces Extraordinary General Meeting for Rights Issue Approval
PremiumCompany Announcements
Oncoinvent ASA Announces Extraordinary General Meeting for Rights Issue Approval
3M ago
Oncoinvent ASA Launches NOK 130 Million Rights Issue to Advance Cancer Therapy Development
PremiumCompany Announcements
Oncoinvent ASA Launches NOK 130 Million Rights Issue to Advance Cancer Therapy Development
3M ago
Oncoinvent ASA Announces NOK 130 Million Rights Issue to Advance Cancer Therapy Development
PremiumCompany Announcements
Oncoinvent ASA Announces NOK 130 Million Rights Issue to Advance Cancer Therapy Development
3M ago
Oncoinvent ASA Announces NOK 130 Million Rights Issue
PremiumCompany AnnouncementsOncoinvent ASA Announces NOK 130 Million Rights Issue
3M ago
Oncoinvent ASA Announces NOK 130 Million Rights Issue to Bolster Clinical Trials
Premium
Company Announcements
Oncoinvent ASA Announces NOK 130 Million Rights Issue to Bolster Clinical Trials
3M ago
Oncoinvent Reports Promising Clinical Data for Radspherin®
Premium
Company Announcements
Oncoinvent Reports Promising Clinical Data for Radspherin®
4M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >